logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24
STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]
Read More

Inify Laboratories – More diagnoses delivered in the first quarter than in the whole of 2023

Financial reports, Investor News 2024-04-24
STOCKHOLM – April 24, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw a 184% increase in sales in Q1 2024, compared to the […]
Read More

Inify Laboratories – Annual Report 2023

Annual reports, Financial reports, Investor News 2024-04-11
Stockholm – April 11, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2023. […]
Read More

Foresees a noticeable increase of customers, volume, and sales in 2024

Financial reports, Investor News 2024-02-29
STOCKHOLM – February 29, 2024 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, saw important pieces fall into place during the fourth quarter, the foremost […]
Read More

Continuous diagnostic operation and very positive feedback from customers

Financial reports, Investor News 2023-10-24
STOCKHOLM – October 24, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has had a continuous inflow of patient samples for diagnosis, which is […]
Read More

Inify Laboratories – Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis

Financial reports, Investor News 2023-08-23
STOCKHOLM – August 23, 2023 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, successfully launched in the second quarter 2023. “We launched our laboratory service […]
Read More

Inify Laboratories – Strong market interest and launch on track

Financial reports, Investor News 2023-04-26
STOCKHOLM – April 26th, 2023 – Inify Laboratories, a fully integrated digital ultramodern laboratory service that provides cancer diagnostics within pathology, is on track for launch at the end of […]
Read More

Inify Laboratories – Annual Report 2022

Annual reports, Financial reports, Investor News 2023-04-12
Stockholm – April 12, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, […]
Read More

Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time

Financial reports, Investor News 2023-02-22
STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has completed its new laboratory – including staffing up with skilled […]
Read More

Inify Laboratories – Laboratory and recruitment on track with positive market feedback

Financial reports, Investor News 2022-10-26
STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated […]
Read More
  • 1
  • 2
  • 3
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calendar

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories